Innate Pharma SA Other Comprehensive Income Net Of Tax Exchange Differences On Translation
Innate Pharma SA (IPHA) reported Other Comprehensive Income Net Of Tax Exchange Differences On Translation of EUR 997.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation · last filed 2026-04-01
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 6 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month |
|---|---|---|
| 2025-12-31 | 997.00K EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 1.02M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | -504.00K EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | -257.00K EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 276.00K EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 146.00K EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | -428.00K EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | -670.00K EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | -483.00K EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | -178.00K EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 222.00K EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | -13.00K EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 5.00K EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | -26.00K EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 68.00K EUR 20-F · filed 2020-04-24 |